BonAlive Biomaterials launches osteostimulative BonAlive putty

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version of their osteostimulative BonAlive^® bioactive glass bone regeneration technology.

The launch of the osteostimulative BonAlive^® putty is an important milestone in the commercialization strategy of the BonAlive^® product family. The current BonAlive^® granules products have been approved for orthopaedic use since 2006 and for bone cavity filling in the treatment of chronic osteomyelitis since March 2011. "As an extension to the BonAlive^® granules product line, the BonAlive^® putty will significantly strengthen our position in the trauma and spine market as surgeons are increasingly demanding products that are both easy and ready-to-use while delivering a solid clinical outcome" said Dr. Fredrik Ollila, CEO of BonAlive Biomaterials Ltd.